Abstract:Multimodal imaging unfolds as an innovative approach that synergistically employs a spectrum of imaging techniques either simultaneously or sequentially. The integration of computed tomography (CT), magnetic resonance imaging (MRI), single-photon emission computed tomography (SPECT), positron emission tomography (PET), and optical imaging (OI) results in a comprehensive and complementary understanding of complex biological processes. This innovative approach combines the strengths of each method and overcoming their individual limitations. By harmoniously blending data from these modalities, it significantly improves the accuracy of cancer diagnosis and aids in treatment decision-making processes. Nanoparticles possess a high potential for facile functionalization with radioactive isotopes and a wide array of contrast agents. This strategic modification serves to augment signal amplification, significantly enhance image sensitivity, and elevate contrast indices. Such tailored nanoparticles constructs exhibit a promising avenue for advancing imaging modalities in both preclinical and clinical setting. Furthermore, nanoparticles function as a unified nanoplatform for the co-localization of imaging agents and therapeutic payloads, thereby optimizing the efficiency of cancer management strategies. Consequently, radiolabeled nanoparticles exhibit substantial potential in driving forward the realms of multimodal imaging and theranostic applications. This review discusses the potential applications of molecular imaging in cancer diagnosis, the utilization of nanotechnology-based radiolabeled materials in multimodal imaging and theranostic applications, as well as recent advancements in this field. It also highlights challenges including cytotoxicity and regulatory compliance, essential considerations for effective clinical translation of nanoradiopharmaceuticals in multimodal imaging and theranostic applications.

Advanced Nanomaterials for Multimodal Molecular Imaging

Multimodal nanoparticle imaging agents: design and applications

Nanotechnology for Enhancing Medical Imaging

Enhancing biomedical imaging: the role of nanoparticle-based contrast agents

Magnetic and fluorescent nanoparticles for multimodality imaging

Radioactive Nanomaterials for Multimodality Imaging.

Advances of functional nanomaterials for magnetic resonance imaging and biomedical engineering applications

Advances of Functional Nanomaterials for Magnetic Resonance Imaging and Biomedical Engineering Applications.

Polymer-assisted Nanoparticulate Contrast-Enhancing Materials

Multimodal Molecular Imaging: Current Status and Future Directions

Advances in Multifunctional Nano-Sized CT Contrast Agents

Advanced Functional Nanomaterials for Theranostics

Nanoscale contrast agents: A promising tool for ultrasound imaging and therapy.

Nanomaterials for Fluorescence and Multimodal Bioimaging

Advances in nanotechnology-based targeted-contrast agents for computed tomography and magnetic resonance

Advances of Upconversion Nanoparticles for Molecular Imaging

Radiolabeled PET/MRI Nanoparticles for Tumor Imaging

Nanomaterial-based contrast agents for common disease imaging

Multimodality Imaging Agents with PET as the Fundamental Pillar.

Multimodal Contrast Agents for Optoacoustic Brain Imaging in Small Animals

Exploring innovative strides in radiolabeled nanoparticle progress for multimodality cancer imaging and theranostic applications